Spread the word
Help raise awareness of the impact of lung cancer in Australia and the critical steps government can take to turn the tide and save lives. Share via your social media channels today!
Help raise awareness of the impact of lung cancer in Australia and the critical steps government can take to turn the tide and save lives. Share via your social media channels today!
Find out how you can become a lung cancer patient advocate with Lung Foundation Australia and help shape real and lasting change.
The Next Breath: Accelerating Lung Cancer Reform in Australia 2022-25 is the second national blueprint for action. Read more about lung cancer in Australia and the six recommendations for reform.
I'm a youth worker, I love looking after my family, I’ve got great kids and a wife and I love playing a role in the community.
Lung cancer should be as equal as any other cancer in the care that is provided to us.
I’m a mother, a wife and a person.
I don’t understand why it’s so difficult in Australia when all the other cancers get so much attention.
I can hardly describe the difference a nurse who knows the disease and knows the implication of living with the disease makes to the disease journey.
I love my daughters and just want to be there for them not only as a father, but as their kids’ grandfather.
I ran a half marathon the weekend before I was diagnosed. Of every cancer I thought I could get, lung cancer was at the bottom of the list.
I’m an artist, a festival director, a mum, a step mum, and a fiancée.
A screening program is needed so people aren’t finding out as late as I did so they can receive treatment and get well.
One doctor said I had a 1 in 4 chance of survival, another said a 1 in 10 chance of survival. Being an accountant, I wasn’t happy with either odds.
Do you have a story that you would like to share? Your experience can be powerful in calling on the government to invest in lung cancer. Please get in contact with us.
The Blueprint development and launch was funded by Lung Ambition Alliance and AstraZeneca.